ImaRx Pharmaceutical, Inc. Healthcare & Life SciencesCapital Raise Jun 1 Written By Emily Dyer-Wolfe ImaRx Pharmaceutical, Inc. Sale of ImaRx Pharmaceuticals, Inc. to DuPont for $44 Million in DuPont Common Stock. Sale included the rights to the lipid based imaging patent for cardiovascular pharmaceuticals only on a world-wide basis. Emily Dyer-Wolfe
ImaRx Pharmaceutical, Inc. Healthcare & Life SciencesCapital Raise Jun 1 Written By Emily Dyer-Wolfe ImaRx Pharmaceutical, Inc. Sale of ImaRx Pharmaceuticals, Inc. to DuPont for $44 Million in DuPont Common Stock. Sale included the rights to the lipid based imaging patent for cardiovascular pharmaceuticals only on a world-wide basis. Emily Dyer-Wolfe